Overview of Dr. Kumar
Dr. Anita Kumar is an oncologist in New York, NY and is affiliated with multiple hospitals in the area, including Memorial Sloan Kettering Cancer Center and Memorial Hospital for Cancer and allied Diseases. She received her medical degree from McGaw Medical Center of Northwestern University and has been in practice 9 years. She is one of 475 doctors at Memorial Sloan Kettering Cancer Center and one of 90 doctors at Memorial Hospital for Cancer and allied Diseases who specialize in Oncology. She has more than 30 publications and over 300 citings.
Office
Memorial Sloan Kettering Cancer Center Basking Ridge
136 Mountain View Boulevard
New York, NY 10021- Is this information wrong?
Education & Training
- Memorial Sloan Kettering Cancer CenterFellowship, Hematology and Medical Oncology, 2011 - 2014
- Brigham and Women's HospitalResidency, Internal Medicine, 2008 - 2011
- Northwestern University The Feinberg School of MedicineClass of 2008
- Harvard CollegeBA, Biochemical Sciences, Cum Laude, 1999 - 2004
Certifications & Licensure
- FL State Medical License 2021 - Present
- NY State Medical License 2011 - 2026
- NJ State Medical License 2018 - 2025
- PA State Medical License 2020 - 2024
- MA State Medical License 2010 - 2011
Clinical Trials
- Study of Ibrutinib in Relapsed and Refractory T-cell Lymphoma Start of enrollment: 2015 Jan 01
- The Study of Bendamustine, Rituximab, Ibrutinib, and Venetoclax in Relapsed, Refractory Mantle Cell Lymphoma Start of enrollment: 2017 Sep 20
- A Study of Tafasitamab and Lenalidomide in People With Mantle Cell Lymphoma Start of enrollment: 2023 Mar 14
Roles: Contact, Principal Investigator
- Join now to see all
Publications & Presentations
PubMed
- 74 citationsPatterns of survival in patients with recurrent mantle cell lymphoma in the modern era: progressive shortening in response duration and survival after each relapse.Anita Kumar, Fushen Sha, Ahmed Toure, Ahmet Dogan, Andy Ni
Blood Cancer Journal. 2019-05-20 - 15 citationsAdolescent and young adult cancer care: Financial hardship and continued uncertainty.Susan K. Parsons, Anita Kumar
Pediatric Blood & Cancer. 2018-12-16 - 4 citationsNovel Agents in Mantle Cell LymphomaAnita Kumar
Current Oncology Reports. 2015-06-05
Abstracts/Posters
- Genomic Profiling of Mantle Cell Lymphoma Suggests Poor-Risk Profile Is Present at Diagnosis and Does Not Arise By Tumor EvolutionAnita Kumar, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- High Complete Response Rate Observed with Second-Line Chemo-Immunotherapy with Pembrolizumab and GVD (Gemcitabine, Vinorelbine, and Liposomal Doxorubicin) in Relapsed ...Anita Kumar, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- Expectant Management of Extranodal Marginal Zone Lymphoma of Bronchial-Associated Lymphoid Tissue (BALT)Anita Kumar, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- Join now to see all
Press Mentions
- Azar Faulted Workers’ ‘Home and Social’ Situations for Meatpacking OutbreaksMay 7th, 2020
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: